The global anti-microbial/anti-fungal tests market is on a growth trajectory, with its valuation projected to rise from $2.5 billion in 2022 to approximately $4.5 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.7% over the forecast period.
Molecular-based tests dominated the market in 2021, accounting for nearly 53.5% of the total share, and are expected to maintain their leadership through 2032. These tests offer superior accuracy, faster results, and the ability to detect genetic markers for resistance, making them the preferred choice for healthcare providers.
The market’s expansion is fueled by increasing incidences of microbial and fungal infections, coupled with rising awareness about early and accurate diagnostics. Technological advancements in molecular diagnostics and the growing adoption of point-of-care testing solutions are further accelerating market growth.
Get Full Report Now – https://www.futuremarketinsights.com/reports/anti-microbial-anti-fungal-tests-market
Key Takeaways:
- Market Growth: Valuation projected to grow from $2.5 billion in 2022 to ~$4.5 billion by 2032 at a CAGR of 5.7%.
- Leading Segment: Molecular-based tests held 53.5% of the market share in 2021, driven by their accuracy and rapid turnaround.
- Driving Factors: Rising prevalence of infections, growing demand for early diagnosis, and advancements in diagnostic technologies.
- Future Trends: Increased adoption of point-of-care and molecular testing solutions to drive growth further.
The anti-microbial/anti-fungal tests market reflects the healthcare sector’s commitment to combating infectious diseases through innovative and precise diagnostic solutions, paving the way for improved patient outcomes.
Growth Drivers
- Rising Incidence of Infectious Diseases: The increasing prevalence of infections, particularly those caused by resistant strains of bacteria and fungi, is driving the demand for effective diagnostic tests.
- Technological Advancements: Innovations in testing methodologies, including molecular-based tests, are enhancing the accuracy and speed of microbial detection, contributing to market growth.
- Growing Awareness of Antimicrobial Resistance: Heightened awareness regarding antimicrobial resistance (AMR) among healthcare professionals and the public is leading to increased demand for reliable testing solutions.
- Government Initiatives: Various government programs aimed at improving infection control and management practices are promoting the adoption of antimicrobial testing technologies.
Regional Insights
- The market is expected to see significant growth in regions like North America, driven by advanced healthcare infrastructure and a focus on combating antimicrobial resistance.
- Emerging markets in the Asia-Pacific region are also anticipated to grow rapidly due to increasing investments in healthcare and rising awareness about infectious diseases.
Competitive Landscape
With several competitors in the anti-microbial/anti-fungal tests market, the overall market is fragmented. To meet consumer demand and expand their customer base, these companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.
- In July 2022, Roche announced that Elecsys HCV Duo immunoassay is now available in countries that accept the CE Mark. Elecsys HCV Duo is the only immunoassay on the market that can determine hepatitis C virus (HCV) antigen and antibody status from a single human plasma or serum sample.
- In June 2022, Meridian Bioscience, Inc., a global leader in diagnostic testing solutions and life science raw materials, introduced two new sample-specific master mixes, Lyo-Ready Direct DNA qPCR Stool Mix and Lyo-Ready Direct RNA/DNA qPCR Stool Mix. These novel master mixes increase the molecular detection of DNA and RNA from crude faecal materials while allowing diagnostic procedures to be room temperature stabilised.
Key Companies Profiled
- Abbott Laboratories
- bioMérieux SA
- Bio-Rad Laboratories Inc
- Bruker Corporation
- Danaher Corporation
- Erba Mannheim
- F. Hoffmann-La Roche AG
- Luminex Corporation
- Meridian Bioscience Inc
- Norgen Biotek Corp
- Omega Diagnostics Group Plc
- Qiagen N.V
- Quidel Corporation
- Thermo Fisher Scientific Inc
Key Market Segments Covered in Anti-microbial/Anti-fungal Tests Industry Research
By Tests Type:
- Molecular Based Tests
- PCR Test
- DNA Microarray
- Phenotypic Resistance Tests
- Complex Test Panels
- Mass Spectrometry
- Rapid Diagnostic Tests
- E-Test Antibiotic/Antifungal Strips
- Biosensor Platforms
By Infection Type:
- Antimicrobial Resistance
- Methicillin-Resistant Staphylococcus Aureus
- Vancomycin-Resistant Enterococcus
- Multi-Drug-Resistant Mycobacterium tuberculosis
- Carbapenem-Resistant Enterobacteriaceae gut bacteria
- Microbial Infection
- Antifungal Resistance
- Candida infections
- Aspergillus infection
- Fusariosis
- Others
- Fungal Infection
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Community Health Centers
- Reference Laboratories
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
